Intriguing structure-activity relations underlie the potent inhibition of HIV protease by norstatine-based peptides.
Tam
T F
TF
Syntex Research Canada, Mississauga, Ontario.
Carrière
J
J
MacDonald
D
D
Castelhano
A L
AL
Pliura
D H
DH
Dewdney
N J
NJ
Thomas
E M
EM
Bach
C
C
Barnett
J
J
Chan
H
H
D000614:Aminocaproates / Q000737:chemistry* / Q000494:pharmacology; D017320:HIV Protease Inhibitors; D015497:HIV-1 / Q000201:enzymology*; D015394:Molecular Structure; D010455:Peptides / Q000737:chemistry / Q000494:pharmacology*; D011487:Protein Conformation; D013329:Structure-Activity Relationship
D000614:Aminocaproates; D017320:HIV Protease Inhibitors; D010455:Peptides; C034495:3-amino-2-hydroxy-5-methylhexanoic acid